0.80
-0.0044(-0.54%)
Currency In USD
| Previous Close | 0.81 |
| Open | 0.82 |
| Day High | 0.87 |
| Day Low | 0.8 |
| 52-Week High | 2.86 |
| 52-Week Low | 0.63 |
| Volume | 720,294 |
| Average Volume | 915,701 |
| Market Cap | 16.73M |
| PE | 3.22 |
| EPS | 0.25 |
| Moving Average 50 Days | 1.34 |
| Moving Average 200 Days | 1.59 |
| Change | -0 |
If you invested $1000 in Longeveron Inc. (LGVN) since IPO date, it would be worth $10.86 as of August 19, 2025 at a share price of $0.805. Whereas If you bought $1000 worth of Longeveron Inc. (LGVN) shares 3 years ago, it would be worth $15.24 as of August 19, 2025 at a share price of $0.805.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
GlobeNewswire Inc.
Aug 11, 2025 8:15 PM GMT
$5.0 million upfront with up to an additional $12.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsMIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a
Longeveron Announces Up To $17.5 Million Public Offering
GlobeNewswire Inc.
Aug 08, 2025 5:28 PM GMT
$5.0 million upfront with up to an additional $12.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrantsMIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a
Longeveron® to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025
GlobeNewswire Inc.
Aug 05, 2025 1:15 PM GMT
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, today ann